floxuridine has been researched along with Skin Neoplasms in 18 studies
Floxuridine: An antineoplastic antimetabolite that is metabolized to fluorouracil when administered by rapid injection; when administered by slow, continuous, intra-arterial infusion, it is converted to floxuridine monophosphate. It has been used to treat hepatic metastases of gastrointestinal adenocarcinomas and for palliation in malignant neoplasms of the liver and gastrointestinal tract.
floxuridine : A pyrimidine 2'-deoxyribonucleoside compound having 5-fluorouracil as the nucleobase; used to treat hepatic metastases of gastrointestinal adenocarcinomas and for palliation in malignant neoplasms of the liver and gastrointestinal tract.
Skin Neoplasms: Tumors or cancer of the SKIN.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A left radical mastectomy was performed on a 53-year-old woman, diagnosed with left inflammatory breast cancer, after local arterial chemotherapy with cyclophosphamide (CPA), doxorubicin and 5-fluorouracil (5-FU)." | 7.70 | [A case of recurrent breast cancer with carcinoma erysipeloides responding to sequential therapy with docetaxel (TXT) and doxifluridine (5'-DFUR) accompanied by leucovorin (LV)]. ( Gen, T; Hara, Y; Igarashi, K; Jibiki, M; Kawasaki, T; Kikuchi, M; Kudoh, A; Noguchi, N; Yabata, E, 2000) |
| "High-dose toremifene therapy (120 mg/day) is useful for the recurrence of receptor-positive breast cancer." | 3.74 | [Evaluation of combination therapy of high-dose toremifene and oral chemotherapy]. ( Murakami, S; Yamamoto, Y, 2007) |
| "A left radical mastectomy was performed on a 53-year-old woman, diagnosed with left inflammatory breast cancer, after local arterial chemotherapy with cyclophosphamide (CPA), doxorubicin and 5-fluorouracil (5-FU)." | 3.70 | [A case of recurrent breast cancer with carcinoma erysipeloides responding to sequential therapy with docetaxel (TXT) and doxifluridine (5'-DFUR) accompanied by leucovorin (LV)]. ( Gen, T; Hara, Y; Igarashi, K; Jibiki, M; Kawasaki, T; Kikuchi, M; Kudoh, A; Noguchi, N; Yabata, E, 2000) |
| "Frequency and distribution of 5-fluorodeoxyuridine (5-FdU) plus caffeine-induced fragile sites on chromosomes of peripheral blood lymphocytes (PBL) from 10 patients with cutaneous melanoma were studied in comparison with 10 PBL samples from normal donors of corresponding sex and age." | 3.68 | Enhanced expression of 1p32 and 1p22 fragile sites in lymphocytes in cutaneous malignant melanomas. ( Chebotarev, AN; Demidov, LV; Kirichenko, OP; Kopnin, BP; Mukeria, AF; Sokova, OI, 1992) |
| "With a diagnosis of advanced breast cancer with skin invasion, she underwent right mastectomy with a free skin graft." | 1.32 | Massive mucinous carcinoma of the breast untreated for 6 years. ( Sakaguchi, K; Tsuchie, K; Yoneyama, F, 2003) |
| "The results of treatment of gastric cancer with docetaxel have scarcely been reported." | 1.31 | [A case of multiple skin metastases from gastric cancer successfully treated with docetaxel combined with doxifluridine]. ( Ideguchi, K; Ikeda, Y; Mori, T; Nakagawa, K; Okamoto, K; Sakata, K; Yasumitsu, T, 2002) |
| " FUdR was found to be chemically toxic in itself to 2 canine tissue culture lines at doses used in the literature to increase 125IUdR uptake." | 1.27 | The toxicity of fluorodeoxyuridine when used to increase the uptake of 125I-iododeoxyuridine into tissue culture cells in vitro. ( Holmes, JM, 1983) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (38.89) | 18.7374 |
| 1990's | 4 (22.22) | 18.2507 |
| 2000's | 7 (38.89) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mori, T | 1 |
| Ikeda, Y | 1 |
| Okamoto, K | 1 |
| Sakata, K | 1 |
| Ideguchi, K | 1 |
| Nakagawa, K | 1 |
| Yasumitsu, T | 1 |
| Mader, RM | 1 |
| Schrolnberger, C | 1 |
| Rizovski, B | 1 |
| Brunner, M | 1 |
| Wenzel, C | 1 |
| Locker, G | 1 |
| Eichler, HG | 1 |
| Mueller, M | 1 |
| Steger, GG | 1 |
| Sawada, M | 1 |
| Ono, Y | 1 |
| Fukushima, M | 1 |
| Zimmermann, A | 1 |
| Walt, H | 1 |
| Haller, U | 1 |
| Baas, P | 1 |
| Klein, SD | 1 |
| Yoneyama, F | 1 |
| Tsuchie, K | 1 |
| Sakaguchi, K | 1 |
| Murakami, S | 1 |
| Yamamoto, Y | 1 |
| Holmes, JM | 1 |
| Bollag, W | 1 |
| Hartmann, HR | 1 |
| Tajima, H | 1 |
| Matsuki, N | 1 |
| Takeda, T | 1 |
| Horichi, H | 1 |
| Kumaki, T | 1 |
| Shima, K | 1 |
| Hara, Y | 1 |
| Kawasaki, T | 1 |
| Yabata, E | 1 |
| Gen, T | 1 |
| Jibiki, M | 1 |
| Kudoh, A | 1 |
| Noguchi, N | 1 |
| Igarashi, K | 1 |
| Kikuchi, M | 1 |
| Jato, JG | 1 |
| Lake, LM | 1 |
| Grunden, EE | 1 |
| Johnson, BM | 1 |
| Sokova, OI | 1 |
| Kirichenko, OP | 1 |
| Mukeria, AF | 1 |
| Demidov, LV | 1 |
| Chebotarev, AN | 1 |
| Kopnin, BP | 1 |
| Firestone, WM | 1 |
| FitzGerald, GB | 1 |
| Wick, MM | 1 |
| Zhao, L | 1 |
| Kaneda, T | 1 |
| Tohnai, I | 1 |
| Shinoda, T | 1 |
| Kasuya, Y | 1 |
| Matsuyama, M | 1 |
| Komuro, K | 1 |
| Mitsumori, N | 1 |
| Iwamoto, K | 1 |
| Murai, R | 1 |
| Ishida, T | 1 |
| Nagasaki, Y | 1 |
| Hujii, Y | 1 |
| Amano, R | 1 |
| Yamazaki, M | 1 |
| Nagayama, A | 1 |
| Arata, T | 1 |
| Tanaka, S | 1 |
| Southam, CM | 1 |
| Johnson, FD | 1 |
| Jacobs, EM | 1 |
| Sullivan, RD | 1 |
| Miller, E | 1 |
18 other studies available for floxuridine and Skin Neoplasms
| Article | Year |
|---|---|
[A case of multiple skin metastases from gastric cancer successfully treated with docetaxel combined with doxifluridine].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Drug Administration Schedule; Floxu | 2002 |
Penetration of capecitabine and its metabolites into malignant and healthy tissue of patients with advanced breast cancer.
Topics: Administration, Oral; Antimetabolites, Antineoplastic; Breast Neoplasms; Capecitabine; Deoxycytidine | 2002 |
[A case of advanced recurrent breast cancer responding to treatment with weekly docetaxel combined with doxorubicin].
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Combine | 2003 |
Effects of chlorin-mediated photodynamic therapy combined with fluoropyrimidines in vitro and in a patient.
Topics: Apoptosis; Breast Neoplasms; Carcinoma, Basal Cell; Floxuridine; Fluorouracil; Humans; Male; Mesopor | 2003 |
Massive mucinous carcinoma of the breast untreated for 6 years.
Topics: Adenocarcinoma, Mucinous; Biopsy, Needle; Breast Neoplasms; Chemotherapy, Adjuvant; Female; Floxurid | 2003 |
[Evaluation of combination therapy of high-dose toremifene and oral chemotherapy].
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Capecitabine | 2007 |
The toxicity of fluorodeoxyuridine when used to increase the uptake of 125I-iododeoxyuridine into tissue culture cells in vitro.
Topics: Animals; Cell Line; Cells; Culture Techniques; Dogs; Floxuridine; Idoxuridine; Iodine Radioisotopes; | 1983 |
Tumor inhibitory effects of a new fluorouracil derivative: 5'-deoxy-5-fluorouridine.
Topics: Animals; Female; Floxuridine; Lethal Dose 50; Lung Neoplasms; Mice; Neoplasms, Experimental; Sarcoma | 1980 |
[A case of cutaneous and brain metastasis of gastric carcinoma, treated effectively by chemotherapy with CDDP, MMC, etoposide and 5'-DFUR].
Topics: Adenocarcinoma; Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Ne | 1994 |
[A case of recurrent breast cancer with carcinoma erysipeloides responding to sequential therapy with docetaxel (TXT) and doxifluridine (5'-DFUR) accompanied by leucovorin (LV)].
Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; | 2000 |
Effect of deoxyuridine coadministration on toxicity and antitumor activity of fluorouracil and floxuridine.
Topics: Animals; Antineoplastic Agents; Biological Assay; Deoxyuridine; Drug Combinations; Drug Synergism; F | 1975 |
Enhanced expression of 1p32 and 1p22 fragile sites in lymphocytes in cutaneous malignant melanomas.
Topics: Adult; Caffeine; Cells, Cultured; Chromosome Fragile Sites; Chromosome Fragility; Chromosomes, Human | 1992 |
A comparison of the effects of antitumor agents upon normal human epidermal keratinocytes and human squamous cell carcinoma.
Topics: Carcinoma, Squamous Cell; Cell Division; Cell Line; DNA; DNA, Neoplasm; Floxuridine; Humans; Keratin | 1990 |
[Experimental study relating to the anti-cancer effect of doxifluridine].
Topics: Administration, Oral; Animals; Antineoplastic Agents; Carcinoma, Squamous Cell; Drug Screening Assay | 1990 |
[A case of remission of metastatic gastric cancer lesions in the chest and abdominal wall by 5'-DFUR administration].
Topics: Abdominal Muscles; Adenocarcinoma; Administration, Oral; Antineoplastic Agents; Female; Floxuridine; | 1985 |
Joint oncogenic action of antimetabolites and 3-methylcholanthrene in mice.
Topics: Animals; Antimetabolites; Chloramphenicol; Drug Synergism; Female; Floxuridine; Idoxuridine; Methylc | 1968 |
Chemotherapy of metastatic malignant melanoma. Experience with 73 patients.
Topics: Adult; Aged; Antineoplastic Agents; Chlorambucil; Colchicine; Cyclophosphamide; Cytarabine; Eye Neop | 1971 |
The clinical effects of prolonged intravenous infusion of 5-fluoro-2'-deoxyuridine.
Topics: Adenoma, Islet Cell; Aged; Breast Neoplasms; Carcinoma, Squamous Cell; Colonic Neoplasms; Female; Fl | 1965 |